UPDATE: Updated to include information from an SEC filing. Arthromeda said yesterday that it closed a Series D round for an unspecified amount that’s enough to get its ArthroSight-PS hip replacement navigation platform through clinical trials and hoped-for regulatory approvals. The company has raised $1.5 million in a round of equity financing, with 10 anonymous investors taking part, […]
ArthroMeda hauled in $1.6 million in an equity offering it hoped would raise $2 million, according to a regulatory filing.
Ayer, Mass.-based ArthroMeda develops devices used in total hip arthroplasties that are designed to help physicians properly orient hip implants. The company was hoping to bring in $2 million through the equity sale. ArthroMeda brought in 12 backers, according to a regulatory filing.